EQUINOX NEPREMICNINE d.d. (LJSE:EQNX)
59.50
-4.50 (-7.03%)
At close: Jan 30, 2026
6.25% (1Y)
| Market Cap | 106.26M +13.0% |
| Revenue (ttm) | 9.71M +23.5% |
| Net Income | 1.30M -5.2% |
| EPS | 0.73 -3.7% |
| Shares Out | 1.79M |
| PE Ratio | 81.86 |
| Forward PE | n/a |
| Dividend | 1.83 (3.08%) |
| Ex-Dividend Date | n/a |
| Volume | 216 |
| Average Volume | 88 |
| Open | 59.50 |
| Previous Close | 64.00 |
| Day's Range | 59.50 - 59.50 |
| 52-Week Range | 56.00 - 65.50 |
| Beta | -0.03 |
| RSI | 43.44 |
| Earnings Date | Feb 10, 2026 |